Articles About NASDAQ:ARIA
February 25, 2014
Merck has terminated a partnership with Ariad, abandoning a once-promising experimental cancer drug that was rejected by the FDA in 2012.
February 15, 2014
Investors looking to generate substantial gains over the coming years may want to take a look at these small-cap biotechnology companies.